Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibacterial mechanisms identified through structural systems pharmacology.

BMC systems biology - 10 Oct 2013

Chang Roger L, Xie Lei, Bourne Philip E, Palsson Bernhard O

Abstract excerpt

BACKGROUND: The growing discipline of structural systems pharmacology is applied prospectively in this study to predict pharmacological outcomes of antibacterial compounds in Escherichia coli K12. This work builds upon previously established methods for structural prediction of ligand binding poc...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Binding Sites
Share to Escherichia coli K12

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Escherichia coli Proteins

Share to Genomics

Share to Models, Molecular

Share to Protein Conformation

Share to Systems Biology

Source

Open in PubMed Open full text

Identifiers

PMID: 24112686
DOI: 10.1186/1752-0509-7-102
PMCID: PMC3853765

Genes

GEM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24112686-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibacterial mechanisms identified through structural systems pharmacology.PMID 24112686Read ↗

Systems-level antimicrobial drug and drug synergy discovery.Semantic proximity Read ↗

Bridging Drug Discovery through Hierarchical Subtractive Genomics against Asd, Trpg and Secy of Pneumonia Causing MDR Staphylococcus aureusSemantic proximity Read ↗

Aspartate‐β‐semialdeyhyde dehydrogenase as a potential therapeutic target of Mycobacterium tuberculosis H37Rv: Evidence from in silico elementary mode analysis of biological network modelSemantic proximity Read ↗

Integrated Bioinformatics-Based Subtractive Genomics Approach to Decipher the Therapeutic Drug Target and Its Possible Intervention against BrucellosisSemantic proximity Read ↗

Subtractive genomics and drug repurposing strategies for targeting Streptococcus pneumoniae: insights from molecular docking and dynamics simulationsSemantic proximity Read ↗

Systematic discovery of drug interaction mechanisms.Semantic proximity Read ↗

Small Molecule Modulation of Microbiome Ecosystem: A Systems Pharmacology PerspectiveSemantic proximity Read ↗

Quantitative prediction of conditional vulnerabilities in regulatory and metabolic networks using PRIME.Semantic proximity Read ↗

Structural systems pharmacology: a new frontier in discovering novel drug targets.Semantic proximity Read ↗

Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori InfectionSemantic proximity Read ↗

Integrating Network Pharmacology Approaches to Decipher the Multi-Target Pharmacological Mechanism of Microbial Biosurfactants as Novel Green Antimicrobials against ListeriosisSemantic proximity Read ↗

Mechanisms of action and synergies of a novel lipid IV <sub>A</sub> biosynthesis inhibitorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.